Mark Horner

31-33 Manufacturing

325411 Medicinal and Botanical Manufacturing

This industry comprises establishments primarily engaged in (1) manufacturing uncompounded medicinal chemicals and their derivatives (i.e., generally for use by pharmaceutical preparation manufacturers) and/or (2) grading, grinding, and milling uncompounded botanicals.

Average Jobs Employed 19
Average Loan Given $243,084
Number of Loans Given 591
Total Amount Loaned $143,662,816

Manufacturing packaged compounded medicinals and botanicals are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing.

Manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except for diagnostic use) are classified in U.S. Industry 325414, Biological Product (except Diagnostic) Manufacturing.

325412 Pharmaceutical Preparation Manufacturing

This industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

Average Jobs Employed 22
Average Loan Given $381,438
Number of Loans Given 1351
Total Amount Loaned $515,322,883

Manufacturing uncompounded medicinal chemicals and their derivatives are classified in U.S. Industry 325411, Medicinal and Botanical Manufacturing;

Manufacturing in-vitro diagnostic substances are classified in U.S. Industry 325413, In-Vitro Diagnostic Substance Manufacturing.

Manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except for diagnostic use) are classified in U.S. Industry 325414, Biological Product (except Diagnostic) Manufacturing.

325413 In-Vitro Diagnostic Substance Manufacturing

This industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.

Average Jobs Employed 23
Average Loan Given $406,931
Number of Loans Given 71
Total Amount Loaned $28,892,082

Establishments primarily engaged in manufacturing in-vivo diagnostic substances are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing.

325414 Biological Product Manufacturing

This industry comprises establishments primarily engaged in manufacturing vaccines, toxoids, blood fractions, and culture media of plant or animal origin (except diagnostic).

Average Jobs Employed 18
Average Loan Given $272,231
Number of Loans Given 204
Total Amount Loaned $55,535,162

Manufacturing in-vitro diagnostic substances are classified in U.S. Industry 325413, In-Vitro Diagnostic Substance Manufacturing.

Manufacturing pharmaceutical preparations (except biological and in-vitro diagnostic substances) are classified in U.S. Industry 325412, Pharmaceutical Preparation Manufacturing.